HER2 Support Group Forums - View Single Post - Trial for high-risk NEDs

AlaskaAngel · 06-19-2006, 09:36 AM

For those who are high-risk and NED, and can travel to the clinical trial site, this trial might be worthwhile. You can find it at the clinicaltrials.gov website.

Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer

This study is currently recruiting patients.
Verified by National Cancer Institute (NCI) June 2006

Sponsors and Collaborators:Sidney Kimmel Comprehensive Cancer Center National Cancer Institute (NCI)
Information provided by:National Cancer Institute (NCI)ClinicalTrials.gov Identifier:NCT00334542

Purpose

RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of simvastatin may keep cancer from coming back in women who are at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.

PURPOSE: This phase II trial is studying how well simvastatin works in preventing a new breast cancer in women at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.

06-19-2006, 09:36 AM	#1
AlaskaAngel Senior Member Join Date: Sep 2005 Location: Alaska Posts: 2,018	Trial for high-risk NEDs For those who are high-risk and NED, and can travel to the clinical trial site, this trial might be worthwhile. You can find it at the clinicaltrials.gov website. Simvastatin in Preventing a New Breast Cancer in Women Who Are at High Risk for a New Breast Cancer After Undergoing Surgery for Ductal Carcinoma in Situ or Stage I, Stage II, or Stage III Breast Cancer This study is currently recruiting patients. Verified by National Cancer Institute (NCI) June 2006 Sponsors and Collaborators:Sidney Kimmel Comprehensive Cancer Center National Cancer Institute (NCI) Information provided by:National Cancer Institute (NCI)ClinicalTrials.gov Identifier:NCT00334542 Purpose RATIONALE: Chemoprevention is the use of certain drugs to keep cancer from forming, growing, or coming back. The use of simvastatin may keep cancer from coming back in women who are at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer. PURPOSE: This phase II trial is studying how well simvastatin works in preventing a new breast cancer in women at high risk for a new breast cancer after undergoing surgery for ductal carcinoma in situ or stage I, stage II, or stage III breast cancer.